Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.9800
-0.0300 (-2.97%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Employees
Marker Therapeutics had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Marker Therapeutics the 41,894th largest employer in the world and 6,498th in the United States.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$709,334
Profits / Employee
-$1,741,476
Market Cap
16.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | -59 | -88.06% |
| Dec 31, 2022 | 67 | 11 | 19.64% |
| Dec 31, 2021 | 56 | 12 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Pluri | 113 |
| Seres Therapeutics | 66 |
| Acumen Pharmaceuticals | 61 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| Context Therapeutics | 15 |
| Radiopharm Theranostics | 14 |
MRKR News
- 13 days ago - Marker Therapeutics awarded $2.6M FDA Orphan Products development grant - TheFly
- 13 days ago - Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer - GlobeNewsWire
- 5 weeks ago - Marker Therapeutics highlights expanded manufacturing support of CDMO partner - TheFly
- 5 weeks ago - Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies - GlobeNewsWire
- 2 months ago - Marker Therapeutics Quarterly report: Q2 2026 - Filings
- 5 months ago - Marker Therapeutics Quarterly report: Q1 2026 - Filings
- 7 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 7 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings